Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited Mobility
Simulated-Altitude as an Adjunct to Optimize Aerobic Exercise in Obese Breast Cancer Survivors With Limited Ambulatory Function: Pilot Randomized Trial
1 other identifier
interventional
15
1 country
1
Brief Summary
The study will evaluate the utility of hypoxic exercise training to improve cardiovascular and metabolic health among obese breast cancer survivors. While participants exercise, a lower fraction of inspired oxygen will be used to simulate a higher altitude. This approach removes the mechanical strain needed to sustain moderate-to-vigorous exercise intensity which is believed to support exercise tolerance. Participants are randomized to either the treatment (walking+simulated-altitude) or control (walking under normoxic conditions).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Oct 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 12, 2017
CompletedFirst Posted
Study publicly available on registry
January 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedMay 14, 2018
May 1, 2018
1.4 years
January 12, 2017
May 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Determine the feasibility of an 8 week exercise intervention comparing walking+simulated-altitude to walking (control) based on retention.
number of participants completing the 8 week session
baseline to 8 weeks
Determine the feasibility of an 8 week exercise intervention comparing walking+simulated-altitude to walking (control) based on adherence to exercise compliance.
mean compliance among all participantswith exercise prescription
baseline to 8 weeks
Determine the feasibility of an 8 week exercise intervention comparing walking+simulated-altitude to walking (control) based on number of adverse events.
Number of adverse events in each group
baseline to 8 weeks
Secondary Outcomes (11)
The effect sizes for walking+simulated-altitude and walking (control) as measured by a 6 minute walk.
baseline to 8 weeks
The effect sizes for walking+simulated-altitude and walking (control) as measured by the cardiorespiratory fitness.
baseline to 8 weeks
The effect sizes for walking+simulated-altitude and walking (control) as measured by arterial elasticity.
baseline to 8 weeks
The effect sizes for walking+simulated-altitude and walking (control) as measured by resting heart rate variability.
baseline to 8 weeks
The effect sizes for walking+simulated-altitude and walking (control) as measured by the fasting glucose.
baseline to 8 weeks
- +6 more secondary outcomes
Study Arms (2)
Walking+simulated-altitude
EXPERIMENTAL8-week exercise training program that involves 3 supervised, treadmill walking sessions each week with 16% oxygen, which will be administered through an exercise mask.
Walking (control)
ACTIVE COMPARATOR8-week exercise training program that involves 3 supervised, treadmill walking session each week.
Interventions
Participants will walk on a treadmill for up to 50 minutes at a 16% oxygen level (administered via exercise mask), which is similar in altitude to Flagstaff, AZ. The progression of exercise training will be based on a varying percents of heart rate reserve.
Participants will walk on a treadmill for up to 50 minutes.The progression of exercise training will be based on a varying percents of heart rate reserve.
Eligibility Criteria
You may qualify if:
- Physician's medical clearance for participation
- English-speaking women
- years of age with a history of Stage 0-III breast cancer
- Preferred walking speed of less than 2.9 mph as measured by a timed 10 meter walk test (to be performed on-site after consent during preliminary screening) "OR" the inability to complete a 6-minute walk without stopping (to be performed on-site after consent during preliminary screening)
- Body mass index between 30-45 kg/m2
- ≥1 year post-treatment and not currently receiving or planning to receive chemo/radiation therapies
- Not participating in a structured exercise routine
- In the previous 6 months, not engaging in (on average) ≥60 minutes of moderate or ≥30 minutes of vigorous physical activity per week.
You may not qualify if:
- Males
- Dementia
- Medical, psychological, and/or social characteristics that may interfere with the ability to fully participate in the proposed study activities/assessments (e.g., psychosis, schizophrenia)
- Contraindication to participate in regular exercise training
- Unwilling to complete prescribed exercise
- Inability to walk
- Pregnant
- Resting oxygen saturation via pulse oximetry below 90%
- Using home oxygen therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 12, 2017
First Posted
January 24, 2017
Study Start
October 1, 2016
Primary Completion
March 1, 2018
Study Completion
April 1, 2018
Last Updated
May 14, 2018
Record last verified: 2018-05